Exosome Diagnostics and Therapeutics Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Germany, UK, China, Japan - Size and Forecast 2024-2028

Published: Jan 2024

Pages: 164

SKU: IRTNTR71819

Snapshot

Exosome Diagnostics & Therapeutics Market Size 2024-2028

The Exosome Diagnostics and Therapeutics Market size is forecast to increase by USD 687.63 million, at a CAGR (Compound Annual Growth Rate) of 23.36% between 2023 and 2028.

There has been an increased demand for effective drugs for chronic cancer, neurological diseases, and cardiovascular diseases across the world. In addition, extracellular vesicles, especially exosomes, have been explored for cancer immunotherapy. Thus, exosomes function more as an adjuvant-like delivery system of antigens and trigger the immune response. Furthermore, Evox Therapeutics Ltd. Has utilized the DeliverEX platform for developing exosome-based therapeutics for treating rare, life-threatening diseases.

What will be the Size of the Industry during the Market Forecast Period?

To learn more about this report, Download Report Sample

Exosome Diagnostics and Therapeutics Market Segmentation

Application Analysis

The diagnostic segment is estimated to witness significant growth during the forecast period. Exosomes are important for several physiological and pathological processes, such as immunological responses, cancer, cardiovascular disease, and abnormal pregnancies. In addition, reducing the use of invasive procedures and enhancing medical intervention with better accuracy requires the use of liquid biopsy in clinical practice. Furthermore, for customized and precise diagnosis and therapy, non-invasive liquid biopsy demonstrates substantial benefits.

Get a glance at the market contribution of various segments Download PDF Sample

The diagnostic segment was the largest segment and was valued at USD 84.62 million in 2018. Moreover, tumor-derived exosomes (TDEs) are crucial for the development of metastatic niches, immune evasion, and tumor growth, suggesting that TDEs may be extremely useful in determining cancer diagnosis and prognosis and the course of treatment for cancer. For example, the early detection of circulating exoDNA KRAS mutations is common in pancreatic cancer. In addition, given that patients with pancreatic ductal carcinoma (PDAC) and colorectal cancer (CRC) have greater levels of GPC1+ circulating exosomes relative to healthy controls, this could be used as a technique for the early detection of cancers in the digestive tract. Hence, such factors are fuelling the growth of this segment which in turn drives the market growth during the forecast period.

End-user Analysis

Biotechnology and pharmaceutical firms are actively working on the therapeutic potential of exosomes, tiny extracellular vesicles with significant implications for various medical applications. Specifically, exosomes have emerged as promising candidates for cancer immunotherapy, functioning as delivery systems for antigens that trigger immune responses. This versatile approach shows promise for treating tumors, neurological conditions, and cardiovascular ailments. Moreover, exosomes hold great diagnostic potential, offering non-invasive methods for disease detection and monitoring. Pharmaceutical companies are increasingly harnessing exosome-based diagnostics to develop precise and early detection techniques, advancing precision medicine capabilities. Additionally, exosome therapeutics are gaining traction for their ability to deliver drugs with enhanced efficacy and minimal side effects, driving innovation in drug delivery platforms. Collaborations between biotechnology firms are further accelerating research efforts, propelling growth in the global exosome diagnostics and therapeutics market segment.

For additional insights into market segments and their market share contributions, Download Sample Now !

Regional Analysis

For more insights about the market share of various regions Download PDF Sample now!

North America is estimated to contribute 40% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. There has been an increase in the prevalence of chronic and infectious diseases across North America. In addition, the growing demand for research activities to develop new drugs has increased the demand for exosome research products, which, in turn, is boosting the growth of the market in North America. Furthermore, factors such as the increasing number of cancer cases, the growing adoption of technologically advanced biopsy tests, the growing older population, high expenditure on the screening of various types of cancers, and the increasing number of biotechnology and pharmaceutical companies that push the development of new cancer treatment are driving the market growth in North America during the forecast period.

Buy Full Report Now

Key Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Aethlon Medical Inc: The company offers Aethlon Hemopurifier which is a first-in-class technology designed for the rapid depletion of cancer-promoting exosomes and circulating viruses.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.

Key Drivers

The rising research on exosome therapeutics is a primary driver. Exosomes in cardiovascular diseases (CVDs) have become a prominent research field with promising value and potential. In addition, Shanghai Jiao Tong University and Nanjing Medical University are primary research institutions for exosome therapy in CVDs. Furthermore, many research and academic institutes are working on the development of treatment methods using exosomes.

For example, Beni-Suef University in Egypt is working on the effect of microvesicles and exosome therapy on beta-cell mass in type I diabetes. Fujian Medical University in China is working on MSC-derived exosomes for multiple organ dysfunction. In addition, there are several articles and research reports related to exosome treatment for rare diseases, which has brought attention toward exosome therapy.

Significant Trends

A key trend shaping the market growth is the advanced technology in exosome collection. Exosome studies with a combination of immunoaffinity and microfluidic system approaches for more effective exosome collection are among the new technologies employed for exosome isolation. In addition, it aids in manipulating small amounts of fluids, utilizing microchannels through dimensions of tens to hundreds of micrometers.

Moreover, owing to the significant benefits of microfluidic technology, microfluidic devices deliver unique functionality, which has not earlier been possible utilizing traditional methods. In addition, another technology used in exosome tracking cancer is nanoparticle tracking analysis (NTA). Furthermore, it helps to determine the concentration and size distribution of particles.

Major Challenges

Issues associated with the broader use of exosome diagnostics and therapeutics are one of the key challenges hindering market growth. Developing a fast and precise method of exosome isolation is one of the most crucial tasks in the current field of research. In addition, the lack of major standardized techniques for the isolation and purification of exosomes is the major drawback of the exosome diagnostics process. Furthermore, the conventional methods of isolation require multi-step ultracentrifugation.

Moreover, this method is very lengthy and often ends up with the contamination of exosomes with other types of extracellular vesicles. In addition, finding optimal conditions for the production of exosomes by a specific cell type is a major challenge, as it is always a compromise between optimal conditions for growth and those for the production and isolation of exosomes. Hence, such factors are hindering the market growth during the forecast period.

Buy Now Full Report

Key Market Customer Landscape

The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Market Customer Landscape

Market Analyst Overview

The global exosome diagnostic and therapeutic market is thriving, propelled by the study of membrane-bound vesicles released by eukaryotic cells. Exosomes, laden with biomolecules and therapeutic payloads, find diverse applications in molecular diagnosis and drug development, particularly in addressing chronic diseases like cancer, neurodegeneration, and cardiovascular dysfunction. R&D activities in the pharmaceutical and biopharmaceutical sectors, supported by institutions like the University of Pittsburgh and National Institute of Health grants, drive advancements. With their multifunctional properties, exosome therapy holds promise in oncology, including head and neck cancer. End users such as cancer institutes, hospitals, diagnostic centers, medical universities, and not-for-profit organizations play pivotal roles in advancing exosome-based diagnostics and therapeutics.

Segment Overview

The market report provides comprehensive market growth by revenue at global, regional & country levels and provides a market growth analysis of the latest market trends and analysis and growth opportunities from 2024 to 2028.

Application Outlook
- Diagnostic
- Therapeutic
End-user Outlook
- Research and academic institutes
- Pharmaceutical and biotechnology companies
- Commercial
Geography Outlook
- North America
  - The U.S.
  - Canada
- Europe
  - U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of the World (ROW)
  - Australia
  - Argentina
  - Brazil

Exosome Diagnostics and Therapeutics Market Scope
Report Coverage	Details
Page number	164
Base year	2023
Historic period	2018-2022
Forecast period	2024-2028
Growth momentum & CAGR	Accelerate at a CAGR of 23.36%
Market Growth 2024-2028	USD 687.63 million
Market structure	Fragmented
YoY growth 2023-2024(%)	21.73
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 40%
Key countries	US, Germany, UK, China, and Japan
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	Aethlon Medical Inc., Bio Techne Corp., BioCat GmbH, BioVision Inc., Capricor Therapeutics Inc., Cell Guidance Systems Ltd., Clara Biotech Inc., Evox Therapeutics Ltd., Hologic Inc., JSR Life Sciences LLC, Lonza Group Ltd., Merck KGaA, Miltenyi Biotec B.V. and Co. KG, Nanosomix Inc., NX PharmaGen Inc., QIAGEN NV, ReNeuron Group plc, Sarepta Therapeutics Inc, System Biosciences LLC, and Thermo Fisher Scientific Inc.
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our market forecasting report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Download Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the market between 2023 and 2028
Precise estimation of the market size and its contribution to the market in focus on the parent market
Detailed market growth and forecasting analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies' position and classification
Accurate market forecast about upcoming market growth and trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
A thorough market research and growth analysis of the market’s competitive landscape and detailed information about companies
Comprehensive market analysis and report of factors that will challenge the growth of the market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
- Exhibit 06: Executive Summary – Chart on Market Segmentation by End-user
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2023

3.4 Market outlook: Forecast for 2023-2028
- Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global exosome diagnostics and therapeutics market 2018 - 2022
- Exhibit 18: Historic Market Size – Data Table on global exosome diagnostics and therapeutics market 2018 - 2022 ($ million)

4.2 Application Segment Analysis 2018 - 2022
- Exhibit 19: Historic Market Size – Application Segment 2018 - 2022 ($ million)

4.3 End-user Segment Analysis 2018 - 2022
- Exhibit 20: Historic Market Size – End-user Segment 2018 - 2022 ($ million)

4.4 Geography Segment Analysis 2018 - 2022
- Exhibit 21: Historic Market Size – Geography Segment 2018 - 2022 ($ million)

4.5 Country Segment Analysis 2018 - 2022
- Exhibit 22: Historic Market Size – Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2023 and 2028

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2023 and 2028

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2023 and 2028

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2023 and 2028

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2023 and 2028

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2023 and 2028

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Application

6.1 Market segments
- Exhibit 30: Chart on Application - Market share 2023-2028 (%)
- Exhibit 31: Data Table on Application - Market share 2023-2028 (%)

6.2 Comparison by Application
- Exhibit 32: Chart on Comparison by Application
- Exhibit 33: Data Table on Comparison by Application

6.3 Diagnostic - Market size and forecast 2023-2028
- Exhibit 34: Chart on Diagnostic - Market size and forecast 2023-2028 ($ million)
- Exhibit 35: Data Table on Diagnostic - Market size and forecast 2023-2028 ($ million)
- Exhibit 36: Chart on Diagnostic - Year-over-year growth 2023-2028 (%)
- Exhibit 37: Data Table on Diagnostic - Year-over-year growth 2023-2028 (%)

6.4 Therapeutic - Market size and forecast 2023-2028
- Exhibit 38: Chart on Therapeutic - Market size and forecast 2023-2028 ($ million)
- Exhibit 39: Data Table on Therapeutic - Market size and forecast 2023-2028 ($ million)
- Exhibit 40: Chart on Therapeutic - Year-over-year growth 2023-2028 (%)
- Exhibit 41: Data Table on Therapeutic - Year-over-year growth 2023-2028 (%)

6.5 Market opportunity by Application
- Exhibit 42: Market opportunity by Application ($ million)
- Exhibit 43: Data Table on Market opportunity by Application ($ million)

7 Market Segmentation by End-user

7.1 Market segments
- Exhibit 44: Chart on End-user - Market share 2023-2028 (%)
- Exhibit 45: Data Table on End-user - Market share 2023-2028 (%)

7.2 Comparison by End-user
- Exhibit 46: Chart on Comparison by End-user
- Exhibit 47: Data Table on Comparison by End-user

7.3 Research and academic institutes - Market size and forecast 2023-2028
- Exhibit 48: Chart on Research and academic institutes - Market size and forecast 2023-2028 ($ million)
- Exhibit 49: Data Table on Research and academic institutes - Market size and forecast 2023-2028 ($ million)
- Exhibit 50: Chart on Research and academic institutes - Year-over-year growth 2023-2028 (%)
- Exhibit 51: Data Table on Research and academic institutes - Year-over-year growth 2023-2028 (%)

7.4 Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028
- Exhibit 52: Chart on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
- Exhibit 53: Data Table on Pharmaceutical and biotechnology companies - Market size and forecast 2023-2028 ($ million)
- Exhibit 54: Chart on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)
- Exhibit 55: Data Table on Pharmaceutical and biotechnology companies - Year-over-year growth 2023-2028 (%)

7.5 Commercial - Market size and forecast 2023-2028
- Exhibit 56: Chart on Commercial - Market size and forecast 2023-2028 ($ million)
- Exhibit 57: Data Table on Commercial - Market size and forecast 2023-2028 ($ million)
- Exhibit 58: Chart on Commercial - Year-over-year growth 2023-2028 (%)
- Exhibit 59: Data Table on Commercial - Year-over-year growth 2023-2028 (%)

7.6 Market opportunity by End-user
- Exhibit 60: Market opportunity by End-user ($ million)
- Exhibit 61: Data Table on Market opportunity by End-user ($ million)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 63: Chart on Market share by geography 2023-2028 (%)
- Exhibit 64: Data Table on Market share by geography 2023-2028 (%)

9.2 Geographic comparison
- Exhibit 65: Chart on Geographic comparison
- Exhibit 66: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2023-2028
- Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ million)
- Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
- Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)

9.4 Europe - Market size and forecast 2023-2028
- Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
- Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
- Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)

9.5 Asia - Market size and forecast 2023-2028
- Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
- Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
- Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)

9.6 Rest of World (ROW) - Market size and forecast 2023-2028
- Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
- Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
- Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)

9.7 US - Market size and forecast 2023-2028
- Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ million)
- Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
- Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)

9.8 Germany - Market size and forecast 2023-2028
- Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
- Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
- Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)

9.9 UK - Market size and forecast 2023-2028
- Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ million)
- Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
- Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)

9.10 China - Market size and forecast 2023-2028
- Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ million)
- Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
- Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)

9.11 Japan - Market size and forecast 2023-2028
- Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
- Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%)
- Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%)

9.12 Market opportunity by geography
- Exhibit 103: Market opportunity by geography ($ million)
- Exhibit 104: Data Tables on Market opportunity by geography ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 105: Impact of drivers and challenges in 2023 and 2028

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 106: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 107: Overview on factors of disruption

11.4 Industry risks
- Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 109: Vendors covered

12.2 Market positioning of vendors
- Exhibit 110: Matrix on vendor position and classification

12.3 Aethlon Medical Inc.
- Exhibit 111: Aethlon Medical Inc. - Overview
- Exhibit 112: Aethlon Medical Inc. - Business segments
- Exhibit 113: Aethlon Medical Inc. - Key offerings
- Exhibit 114: Aethlon Medical Inc. - Segment focus

12.4 Bio Techne Corp.
- Exhibit 115: Bio Techne Corp. - Overview
- Exhibit 116: Bio Techne Corp. - Business segments
- Exhibit 117: Bio Techne Corp. - Key offerings
- Exhibit 118: Bio Techne Corp. - Segment focus

12.5 Capricor Therapeutics Inc.
- Exhibit 119: Capricor Therapeutics Inc. - Overview
- Exhibit 120: Capricor Therapeutics Inc. - Product / Service
- Exhibit 121: Capricor Therapeutics Inc. - Key offerings

12.6 Evox Therapeutics Ltd.
- Exhibit 122: Evox Therapeutics Ltd. - Overview
- Exhibit 123: Evox Therapeutics Ltd. - Product / Service
- Exhibit 124: Evox Therapeutics Ltd. - Key offerings

12.7 Hologic Inc.
- Exhibit 125: Hologic Inc. - Overview
- Exhibit 126: Hologic Inc. - Business segments
- Exhibit 127: Hologic Inc. - Key news
- Exhibit 128: Hologic Inc. - Key offerings
- Exhibit 129: Hologic Inc. - Segment focus

12.8 JSR Life Sciences LLC
- Exhibit 130: JSR Life Sciences LLC - Overview
- Exhibit 131: JSR Life Sciences LLC - Product / Service
- Exhibit 132: JSR Life Sciences LLC - Key offerings

12.9 Lonza Group Ltd.
- Exhibit 133: Lonza Group Ltd. - Overview
- Exhibit 134: Lonza Group Ltd. - Business segments
- Exhibit 135: Lonza Group Ltd. - Key news
- Exhibit 136: Lonza Group Ltd. - Key offerings
- Exhibit 137: Lonza Group Ltd. - Segment focus

12.10 Merck KGaA
- Exhibit 138: Merck KGaA - Overview
- Exhibit 139: Merck KGaA - Business segments
- Exhibit 140: Merck KGaA - Key news
- Exhibit 141: Merck KGaA - Key offerings
- Exhibit 142: Merck KGaA - Segment focus

12.11 Miltenyi Biotec B.V. and Co. KG
- Exhibit 143: Miltenyi Biotec B.V. and Co. KG - Overview
- Exhibit 144: Miltenyi Biotec B.V. and Co. KG - Product / Service
- Exhibit 145: Miltenyi Biotec B.V. and Co. KG - Key offerings

12.12 Nanosomix Inc.
- Exhibit 146: Nanosomix Inc. - Overview
- Exhibit 147: Nanosomix Inc. - Product / Service
- Exhibit 148: Nanosomix Inc. - Key offerings

12.13 NX PharmaGen Inc.
- Exhibit 149: NX PharmaGen Inc. - Overview
- Exhibit 150: NX PharmaGen Inc. - Product / Service
- Exhibit 151: NX PharmaGen Inc. - Key offerings

12.14 QIAGEN NV
- Exhibit 152: QIAGEN NV - Overview
- Exhibit 153: QIAGEN NV - Product / Service
- Exhibit 154: QIAGEN NV - Key news
- Exhibit 155: QIAGEN NV - Key offerings

12.15 Sarepta Therapeutics Inc
- Exhibit 156: Sarepta Therapeutics Inc - Overview
- Exhibit 157: Sarepta Therapeutics Inc - Product / Service
- Exhibit 158: Sarepta Therapeutics Inc - Key offerings

12.16 System Biosciences LLC
- Exhibit 159: System Biosciences LLC - Overview
- Exhibit 160: System Biosciences LLC - Product / Service
- Exhibit 161: System Biosciences LLC - Key offerings

12.17 Thermo Fisher Scientific Inc.
- Exhibit 162: Thermo Fisher Scientific Inc. - Overview
- Exhibit 163: Thermo Fisher Scientific Inc. - Business segments
- Exhibit 164: Thermo Fisher Scientific Inc. - Key news
- Exhibit 165: Thermo Fisher Scientific Inc. - Key offerings
- Exhibit 166: Thermo Fisher Scientific Inc. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 167: Inclusions checklist
- Exhibit 168: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 169: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 170: Research methodology
- Exhibit 171: Validation techniques employed for market sizing
- Exhibit 172: Information sources

13.5 List of abbreviations
- Exhibit 173: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

exosome diagnostics and therapeutics market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis